SCHEMBL5790901

SCHEMBL5790901

O=Cc1ccccc1OCC(=O)OCC(F)(F)F

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGDR2 Q9Y5Y4 2/20 0.59
ALDH1A1 P00352 8/20 0.51
SMN1; SMN2 Q16637 3/20 0.51
HPGD P15428 2/20 0.51
HTT P42858 1/20 0.51
USP2 O75604 1/20 0.49
MAPT P10636 5/20 0.48
PLA2G1B P04054 1/20 0.48
ATG4B Q9Y4P1 1/20 0.48
LMNA P02545 3/20 0.45
NPC1 O15118 2/20 0.45
RAB9A P51151 2/20 0.45
S1PR4 O95977 1/20 0.45
ITGA4 P13612 1/20 0.45
S1PR1 P21453 1/20 0.45
MAPK1 P28482 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45
TLR9 Q9NR96 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
KMT2A Q03164 3/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1804090 0.81 ALDH1A1 (0.66) PTGDR2ALDH1A1SMN1; SMN2HPGDHTT
SCHEMBL5883219 0.81 USP2 (0.72) PTGDR2ALDH1A1SMN1; SMN2HPGDHTT
SCHEMBL11783230 0.78 PTGDR2 (0.60) PTGDR2ALDH1A1SMN1; SMN2HPGDHTT
SCHEMBL1948329 0.77 PTGDR2 (0.68) PTGDR2ALDH1A1SMN1; SMN2HPGDHTT
SCHEMBL31482051 0.77 RXRA (0.50) PTGDR2ALDH1A1SMN1; SMN2HPGDHTT
SCHEMBL7197459 0.77 PTGDR2 (0.62) PTGDR2ALDH1A1SMN1; SMN2HPGDHTT
SCHEMBL2553005 0.76 KDM4E (0.61) PTGDR2ALDH1A1SMN1; SMN2HPGDHTT
SCHEMBL354835 0.75 PTGDR2 (1.00) PTGDR2ALDH1A1SMN1; SMN2HPGDHTT
SCHEMBL5790903 0.74 PTGDR2 (0.59) PTGDR2ALDH1A1SMN1; SMN2HPGDHTT
SCHEMBL8865140 0.74 PTGDR2 (0.62) PTGDR2ALDH1A1SMN1; SMN2HPGDHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2003057896-A1 METHODS FOR PREPARING ANTHRACYCLINONE DERIVATIVES AND ANTHRACYCLINONE DERIVATIVES PER SE ALBANY MOLECULAR RESEARCH, INC. (US) 2003-07-17 WO claimed
WO-2003057687-A1 METHODS FOR PREPARING DOXORUBICIN DERIVATIVES ALBANY MOLECULAR RESEARCH, INC. (US) 2003-07-17 WO claimed
WO-2006012277-A2 BIOCATALYTIC PROCESS FOR PREPARING ENANTIOMERICALLY ENRICHED PRAMIPEXOLE AMR TECHNOLOGY, INC. (US) 2006-02-02 WO disclosed
WO-2003057896-A1 METHODS FOR PREPARING ANTHRACYCLINONE DERIVATIVES AND ANTHRACYCLINONE DERIVATIVES PER SE ALBANY MOLECULAR RESEARCH, INC. (US) 2003-07-17 WO disclosed
WO-2003057687-A1 METHODS FOR PREPARING DOXORUBICIN DERIVATIVES ALBANY MOLECULAR RESEARCH, INC. (US) 2003-07-17 WO disclosed